You are here: All Products  > Innovent Says PD-1 Meets Survival Endpoint in Phase III NSCLC Trial

Innovent Says PD-1 Meets Survival Endpoint in Phase III NSCLC Trial

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.